ChemoMetec A/S (CHHMF)
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | -- |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -- |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.087 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumables, Services, and Other. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumables segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Services segment provides service packages and its corresponding guarantees. The Other segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1997 and is headquartered in Allerod, Denmark. |
| URL | http://www.chemometec.com |
| Investor Relations URL | N/A |
| HQ State/Province | Capital Region |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | N/A |
| Next Earnings Release | Feb. 02, 2027 (est.) |
| Last Earnings Release | Sep. 10, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 13, 2025 |
Profile
| ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumables, Services, and Other. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumables segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Services segment provides service packages and its corresponding guarantees. The Other segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1997 and is headquartered in Allerod, Denmark. |
| URL | http://www.chemometec.com |
| Investor Relations URL | N/A |
| HQ State/Province | Capital Region |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | N/A |
| Next Earnings Release | Feb. 02, 2027 (est.) |
| Last Earnings Release | Sep. 10, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 13, 2025 |